Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4GC6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,420
Award facts
- Contract value 100% obligated
- $14,420.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 7, 2026, the Defense Logistics Agency awarded a delivery order valued at $14,420.19 to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 Syringe 0.5ML, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract to be performed in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at up to $999,999,999.00 and running through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, operates as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company is a subsidiary of Cencora, Inc., which holds the parent IDC with DLA Troop Support Medical. The contract serves customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the flexible IDC vehicle, demonstrating the contractor's capability to meet federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F4GC6?
SPE2DR26F4GC6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4GC6 worth?
The government has obligated $14,420 on SPE2DR26F4GC6.
Is contract SPE2DR26F4GC6 an order under another contract?
Yes. SPE2DR26F4GC6 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GC6 competed?
The extent of competition for SPE2DR26F4GC6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award